RinLis®

RinLis®
Product Description

Insulin lispro. 
Dosage form: solution for subcutaneous and intravenous injections in 3 ml cartridges and disposable insulin pen. 

·         Widely used fast acting insulin analogue.
·         Characterised by reverse lysine and proline residues on amino acid sequence in the insulin amino acid chain. 
·         Fast absorption from subcutaneous injection sites. 
·         Onset of action after subcutaneous administration – in 15 minutes.
·         0.5-2.5 hours – maximum action. 
·         3-4 hours – duration of action.

 

Geropharm

  • RU
  • 2019
    On CPHI since
Specifications
  • Supplied from
    Russian Federation

Geropharm

  • RU
  • 2019
    On CPHI since

More Products from Geropharm (2)

  • RinGlar®

    Product RinGlar®

    Insulin glargine. 

    Dosage form: solution for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

    ·         Long-acting basal insulin
    ·         Maintains normal physiolo...
  • RinLis®  Mix 25

    Product RinLis® Mix 25

    Insulin lispro biphasic 25.Dosage form: susupension for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

    ·         Has fast and predictable effect and the elimination typical for physiologic insulin secretion.
    ·&nb...

Geropharm resources (1)